{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:43:47Z","timestamp":1790401427456,"version":"4.1.0"},"reference-count":37,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,6,5]]},"DOI":"10.3233\/jad-170201","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T13:03:03Z","timestamp":1494334983000},"page":"747-762","source":"Crossref","is-referenced-by-count":10,"title":["Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer\u2019s Disease Pathology"],"prefix":"10.1177","volume":"58","author":[{"given":"Jun Ku","family":"Chung","sequence":"first","affiliation":[{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Canada"},{"name":"Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Canada"},{"name":"Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Canada"},{"name":"Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan"},{"name":"Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Caravaggio","sequence":"additional","affiliation":[{"name":"Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iwata","sequence":"additional","affiliation":[{"name":"Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada"},{"name":"Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gerretsen","sequence":"additional","affiliation":[{"name":"Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Canada"},{"name":"Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kim","sequence":"additional","affiliation":[{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Canada"},{"name":"Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Canada"},{"name":"Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Shinagawa","sequence":"additional","affiliation":[{"name":"The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raihaan","family":"Patel","sequence":"additional","affiliation":[{"name":"Cerebral Imaging Centre, Douglas Mental Health Institute, McGill University, Montreal, QC, Canada"},{"name":"Department of Psychiatry and Biomedical Engineering, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mallar","family":"Chakravarty","sequence":"additional","affiliation":[{"name":"Cerebral Imaging Centre, Douglas Mental Health Institute, McGill University, Montreal, QC, Canada"},{"name":"Department of Psychiatry and Biomedical Engineering, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Canada"},{"name":"Multimodal Imaging Group - Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Canada"},{"name":"Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan"},{"name":"Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-170201_ref1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170201_ref2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170201_ref3","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.0000000000000467","article-title":"Association of hypometabolism and amyloid levels in aging, normal subjects","volume":"82","author":"Lowe","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-170201_ref4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","article-title":"Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals","volume":"71","author":"Mormino","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-170201_ref5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00019442-200508000-00003","article-title":"Mild cognitive impairment","volume":"13","author":"Feldman","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-170201_ref6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-170201_ref7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-beta peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170201_ref8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","article-title":"Suspected non-Alzheimer disease pathophysiology\u2013concept and controversy","volume":"12","author":"Jack","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-170201_ref9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00401-014-1362-3","article-title":"PART and SNAP","volume":"128","author":"Jack","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-170201_ref10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer\u2019s Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170201_ref11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1474-4422(16)30125-9","article-title":"Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer\u2019s disease pathophysiology (SNAP) or Alzheimer\u2019s disease pathology:A longitudinal study","volume":"15","author":"Burnham","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170201_ref12","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1016\/j.neurobiolaging.2015.08.029","article-title":"Suspected non-AD pathology in mild cognitive impairment","volume":"36","author":"Wisse","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170201_ref13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaneurol.2015.1721","article-title":"Characterizing apolipoprotein E epsilon4 carriers and noncarriers with the clinical diagnosis of mild to moderate Alzheimer dementia and minimal beta-amyloid peptide plaques","volume":"72","author":"Monsell","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-170201_ref14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jalz.2012.01.006","article-title":"Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer\u2019s disease","volume":"9","author":"Duara","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170201_ref15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer\u2019s disease and its outcome: A longitudinal cohort study","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170201_ref16","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamaneurol.2016.2642","article-title":"Longitudinal beta-amyloid deposition and hippocampal volume in preclinical Alzheimer disease and suspected non-Alzheimer disease pathophysiology","volume":"73","author":"Gordon","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-170201_ref17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.23931","article-title":"Mild cognitive impairment due to Alzheimer disease in the community","volume":"74","author":"Petersen","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170201_ref18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/WNL.0000000000001209","article-title":"Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression","volume":"84","author":"Caroli","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-170201_ref19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ana.23816","article-title":"Brain injury biomarkers are not dependent on beta-amyloid in normal elderly","volume":"73","author":"Knopman","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170201_ref20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-015-0152-z","article-title":"Predicting Alzheimer\u2019s disease development: A comparison of cognitive criteria and associated neuroimaging biomarkers","volume":"7","author":"Callahan","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-170201_ref21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jamaneurol.2016.2237","article-title":"Heterogeneity in suspected non-Alzheimer disease pathophysiology among clinically normal older individuals","volume":"73","author":"Mormino","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-170201_ref22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/WNL.0b013e3182a8418b","article-title":"Preclinical AD predicts decline in memory and executive functions in subjective complaints","volume":"81","author":"van Harten","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-170201_ref23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative, Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170201_ref24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170201_ref25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archneurol.2010.284","article-title":"Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer Disease Neuroimaging Initiative","volume":"67","author":"Carmichael","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170201_ref26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.neuroimage.2014.04.054","article-title":"Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates","volume":"101","author":"Pipitone","year":"2014","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-170201_ref27","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/hbm.22092","article-title":"Performing label-fusion-based segmentation using multiple automatically generated templates","volume":"34","author":"Chakravarty","year":"2013","journal-title":"Hum Brain Mapp"},{"key":"10.3233\/JAD-170201_ref28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuroimage.2013.02.003","article-title":"A novel in vivo atlas of human hippocampal subfields using high-resolution 3 T magnetic resonance imaging","volume":"74","author":"Winterburn","year":"2013","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-170201_ref29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3233\/JAD-150679","article-title":"Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairment","volume":"49","author":"Chung","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170201_ref30","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jalz.2012.10.007","article-title":"AV45-A11 study group, Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u2019s disease dementia, mild cognitive impairment, and normal aging","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170201_ref31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: The trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-170201_ref32","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0b013e3182872830","article-title":"Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease","volume":"80","author":"Prestia","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-170201_ref33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170201_ref34","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","article-title":"Cerebral amyloid angiopathy in the brains of patients with Alzheimer\u2019s disease: The CERAD experience, Part XV","volume":"46","author":"Ellis","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JAD-170201_ref35","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer\u2019s disease","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170201_ref36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.23908","article-title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of beta-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170201_ref37","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuroimage.2009.01.057","article-title":"Reducing between scanner differences in multi-center PET studies","volume":"46","author":"Joshi","year":"2009","journal-title":"Neuroimage"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-170201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:52Z","timestamp":1777370632000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-170201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,5]]},"references-count":37,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-170201","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,5]]}}}